Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
2.040
+0.170 (9.09%)
At close: Nov 9, 2026, 4:00 PM EST
2.050
+0.010 (0.49%)
Pre-market: Nov 10, 2026, 4:59 AM EST

Foghorn Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
80.380.8855.4580.3452.21101.14
Short-Term Investments
75.9278.02188.29153.72293.5853.15
Cash & Short-Term Investments
156.22158.89243.75234.06345.8154.29
Cash Growth
-13.34%-34.81%4.14%-32.31%124.12%-16.95%
Receivables
-----300
Prepaid Expenses
2.093.095.856.125.65.27
Restricted Cash
-1.25----
Total Current Assets
158.31163.24249.6240.18351.4459.56
Property, Plant & Equipment
30.6232.8632.6142.9149.456.08
Other Long-Term Assets
2.0221.782.824.094.13
Total Assets
190.95198.1283.98285.92404.88519.77

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.174.273.796.265.413.82
Accrued Expenses
10.211.368.538.43119.56
Current Portion of Leases
3.790.929.078.525.976.99
Current Income Taxes Payable
---0.67--
Current Unearned Revenue
18.8743.1945.6134.5532.8228.32
Other Current Liabilities
2.27-----
Total Current Liabilities
37.3259.7466.9958.4455.2148.69
Long-Term Leases
40.0840.3528.0636.5645.5451.34
Long-Term Unearned Revenue
127.4205.96234.46268.12304322.73
Other Long-Term Liabilities
0.250.56--0.030.14
Total Liabilities
205.04306.6329.51363.11404.77422.9

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.01000
Additional Paid-In Capital
587.42523.94512.52395.2377.23361.13
Retained Earnings
-601.38-632.47-558.18-471.56-373.14-264.26
Comprehensive Income & Other
-0.120.020.14-0.83-3.99-0.01
Total Common Equity
-14.08-108.5-45.53-77.190.1196.87
Shareholders' Equity
-14.08-108.5-45.53-77.190.1196.87
Total Liabilities & Equity
190.95198.1283.98285.92404.88519.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
43.8741.2737.1345.0751.5158.33
Net Cash (Debt)
112.35117.62206.62188.98294.2995.96
Net Cash Growth
-28.78%-43.07%9.33%-35.78%206.69%-7.53%
Net Cash Per Share
1.621.873.764.507.082.58
Filing Date Shares Outstanding
59.9658.755.6142.5741.841.42
Total Common Shares Outstanding
59.9656.6655.5942.2841.841.3
Working Capital
121103.5182.61181.75296.19410.87
Book Value Per Share
-0.23-1.92-0.82-1.830.002.35
Tangible Book Value
-14.08-108.5-45.53-77.190.1196.87
Tangible Book Value Per Share
-0.23-1.92-0.82-1.830.002.35
Machinery
8.988.928.037.736.85.8
Leasehold Improvements
--17.0217.2417.1217.06
SEC Filings: 10-K · 10-Q